Portal de investigación
Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Gonzalez-Vilchez F
- Vazquez de Prada JA
- Arizon Del Prado JM
- Mirabet S
- Diaz-Molina B
- Delgado JF
- Gomez-Bueno M
- Paniagua MJ
- Perez-Villa F
- Roig E
- Brossa V
- Lambert JL
- Crespo-Leiro MG
- Ruiz-Cano MJ
Abstract
The increasing use of proliferation signal inhibitors (PSIs) has raised the issue of their risk profile. We sought to determine the causes, incidence, risk factors, and consequences of withdrawal due to adverse events of PSIs in maintenance heart transplantation.
Datos de la publicación
- ISSN/ISSNe:
- 1053-2498, 1557-3117
- Tipo:
- Article
- Páginas:
- 288-295
- PubMed:
- 22133787
- Factor de Impacto:
- 2,897 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF HEART AND LUNG TRANSPLANTATION ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Cita
Gonzalez F,Vazquez de Prada JA,ALMENAR L,Arizon Del Prado JM,Mirabet S,Diaz B,Delgado JF,Gomez M,Paniagua MJ,Perez F,Roig E,MARTÍNEZ L,Brossa V,Lambert JL,SEGOVIA J,Crespo MG,Ruiz MJ. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation. J. Heart Lung Transplant. 2012. 31. (3):p. 288-295. IF:5,112. (1).